GLP-3-R is a “triple-agonist” metabolic peptide that uniquely targets three different hormone receptors (GLP-1, GIP, and glucagon) to suppress appetite, improve blood sugar control, and increase the body’s calorie-burning energy expenditure. It is still ongoing FDA trials but has shown an average body weight reduction of up to 28%. It is currently being tested for chronic weight management, type 2 diabetes, knee osteoarthritis, and metabolic dysfunction-associated steatotic liver disease.
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Reviews
There are no reviews yet.